7CWA | pdb_00007cwa

Crystal structure of PDE8A catalytic domain in complex with clofarabine


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.80 Å
  • R-Value Free: 
    0.333 (Depositor), 0.205 (DCC) 
  • R-Value Work: 
    0.289 (Depositor) 
  • R-Value Observed: 
    0.291 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7CWA

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors.

Huang, Y.Wu, X.N.Zhou, Q.Wu, Y.Zheng, D.Li, Z.Guo, L.Luo, H.B.

(2020) J Med Chem 63: 15852-15863

  • DOI: https://doi.org/10.1021/acs.jmedchem.0c01573
  • Primary Citation Related Structures: 
    7CWA, 7CWF, 7CWG

  • PubMed Abstract: 

    To validate the hypothesis that Tyr748 is a crucial residue to aid the discovery of highly selective phosphodiesterase 8A (PDE8A) inhibitors, we identified a series of 2-chloroadenine derivatives based on the hit clofarabine. Structure-based design targeting Tyr748 in PDE8 resulted in the lead compound 3a (IC 50 = 0.010 μM) with high selectivity with a reasonable druglike profile. In the X-ray crystal structure, 3a bound to PDE8A with a different mode from 3-isobutyl-1-methylxanthine (a pan-PDE inhibitor) and gave a H-bond of 2.7 Å with Tyr748, which possibly interprets the 220-fold selectivity of 3a against PDE2A. Additionally, oral administration of compound 3a achieved remarkable therapeutic effects against vascular dementia (VaD), indicating that PDE8 inhibitors could serve as potential anti-VaD agents.


  • Organizational Affiliation
    • School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China.

Macromolecule Content 

  • Total Structure Weight: 39.48 kDa 
  • Atom Count: 2,787 
  • Modeled Residue Count: 338 
  • Deposited Residue Count: 338 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A338Homo sapiensMutation(s): 0 
Gene Names: PDE8A
EC: 3.1.4.53
UniProt & NIH Common Fund Data Resources
Find proteins for O60658 (Homo sapiens)
Explore O60658 
Go to UniProtKB:  O60658
PHAROS:  O60658
GTEx:  ENSG00000073417 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO60658
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.80 Å
  • R-Value Free:  0.333 (Depositor), 0.205 (DCC) 
  • R-Value Work:  0.289 (Depositor) 
  • R-Value Observed: 0.291 (Depositor) 
Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 76.261α = 90
b = 132.246β = 90
c = 101.916γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
CrysalisProdata reduction
CrysalisProdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Natural Science Foundation of China (NSFC)China21877134
National Natural Science Foundation of China (NSFC)China81522041

Revision History  (Full details and data files)

  • Version 1.0: 2021-09-01
    Type: Initial release
  • Version 1.1: 2022-03-16
    Changes: Database references
  • Version 1.2: 2023-11-29
    Changes: Data collection, Refinement description
  • Version 1.3: 2024-11-06
    Changes: Structure summary